Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Am J Hypertens ; 27(10): 1268-76, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24687999

RESUMO

BACKGROUND: An animal study reported that TGF-ß1 maturation was linked to the homeostasis of blood pressure and elastogenesis of essential hypertension (EH). Recent advances require further research of TGF-ß1 receptor in EH. METHODS: A case-control study comprised of 2,012 adult hypertension case patients and 2,210 adult control subjects was conducted, and the association with blood pressure was further tested in children. Logistic regression and calculated genetic risk score were used to evaluate the effects of one single nucleotide polymorphism (SNP) and multiple SNPs on EH, respectively. RESULTS: The genetic risk score of 10 SNPs showed a significant association with hypertension; the odds ratio of the upper quartile vs. the lower quartile was 1.282 (P = 4.67 × 10(-3)). rs7256241 in miR-518 was significantly associated with diastolic blood pressure (DBP) change in control subjects (P = 0.002), and this association was also observed in children (P = 0.04). The systolic blood pressure (SBP) and DBP of female patients taking reserpine were higher with the C and G alleles of rs3773661 (P = 0.004) and rs7256241 (P = 0.002), respectively. In patients taking Zhen Ju Jiang Ya tablets, SBP and DBP decreased linearly with rs749794 (P = 0.004 and P = 0.048, respectively). SBP decreased linearly with rs1155705 (P = 0.007) and rs11709624 (P = 0.04), but increased with rs1036096 (P = 0.03) in male patients. In male patients taking Jiang Ya tablets, SBP increased linearly with rs11709624 (P = 0.007), DBP increased linearly with rs1155705 (P = 0.03) whereas decreased with rs7256241 (P = 0.04). CONCLUSIONS: Our results suggest that TGFBR2 and miR-518 harbor variants that increase the risk of EH and affect blood pressure homeostasis as well as efficacy of antihypertensive agents.


Assuntos
Povo Asiático/genética , Medicamentos de Ervas Chinesas/uso terapêutico , Hipertensão/genética , MicroRNAs/genética , Proteínas Serina-Treonina Quinases/genética , Receptores de Fatores de Crescimento Transformadores beta/genética , Idoso , Anti-Hipertensivos/uso terapêutico , Estudos de Casos e Controles , Criança , Chrysanthemum , Clonidina/uso terapêutico , Di-Hidralazina/uso terapêutico , Combinação de Medicamentos , Feminino , Predisposição Genética para Doença , Humanos , Hidroclorotiazida/uso terapêutico , Hipertensão/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único , Prometazina/uso terapêutico , Receptor do Fator de Crescimento Transformador beta Tipo II , Reserpina/uso terapêutico , Rutina/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA